Merck lost a big one yesterday in one of their Vioxx trials. Ted Frank calls it a miscarriage of justice:
This is the fifth plaintiffs’ jury verdict out of twenty-nine Vioxx cases that had been ready for trial (not including two pending mistrials), but with millions of dollars awarded each time, plaintiffs’ attorneys can keep batting below the Mendoza line and make a sizable profit . . .
Related posts:
- Merck sends in the B-team for a physician expert witness
- Merck’s prevailing Vioxx strategy
- Hospital takes a shot at a malpractice jury
- John Edwards calls reducing medical malpractice lawsuits a "good idea"
- John Ritter defendants: "They just lost less"
- Letters to the jury: Look at what your ridiculous award has caused
- The Hurwitz jury: "I went into this blind and came out wishing I was"
KevinMD.com on Facebook
{ 1 comment }
Considering every win is on appeal, and every loss for that matter, the plaintiff’s counsel have likely not seen a dime and there is at present no guarantee they will, so Kevin and Overlawyered’s economic analysis is, shall we say, colored by their bias.
Comments on this entry are closed.